WallStSmart
INKT

Mink Therapeutics Inc

NASDAQ: INKT · HEALTHCARE · BIOTECHNOLOGY

$11.81
+8.55% today

Updated 2026-04-29

Market cap
$55.32M
P/E ratio
P/S ratio
EPS (TTM)
$-2.93
Dividend yield
52W range
$6 – $76
Volume
0.4M

Mink Therapeutics Inc (INKT) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-145.6%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+9.7%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-5.5%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-9.2%
2025-11-14
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2025-12-31$-0.56+17.6%$11.32$11.12-1.8%
2025-11-14$-0.65-828.6%$13.22$12.00-9.2%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.68$-0.56+17.6%
2025-09-30$-0.07$-0.65-828.6%
2025-06-30$-0.07$-1.06-1530.8%
2025-03-31$-0.15$-0.70-366.7%
2024-12-31$-0.08$-0.62-675.0%$3.77B-132.2%
2024-09-30$-0.08$-0.05+37.6%
2024-06-30$-0.10$-0.07+27.3%
2024-03-31$-0.15$-0.11+26.7%
2023-12-31$-0.15$-0.16-6.7%$-11.71B
2023-09-30$-0.18$-0.15+16.7%
2023-06-30$-0.20$-0.18+10.0%
2023-03-31$-0.24$-0.17+29.2%$11.71B

Frequently asked questions

Has Mink Therapeutics Inc beaten earnings estimates?
Mink Therapeutics Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -145.6% over the last 4 quarters.
How does INKT stock react to earnings?
INKT stock has moved an average of -5.5% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.